#United States #New Jersey #Pomerantz #Nano-X Imaging #NNOX

Pomerantz Law Firm Launches Class Action Against Nano-X Imaging

On July 23, 2026, Pomerantz LLP announced the initiation of a class action lawsuit against Nano-X Imaging Ltd., a publicly traded company on NASDAQ under the ticker NNOX. The lawsuit is aimed at protecting the interests of investors by seeking damages for alleged violations of federal securities laws. This legal action has been filed in the United States District Court for the District of New Jersey, and is formally listed under the docket number 26-cv-07062.

Background of the Case

The lawsuit encompasses individuals and entities who purchased or acquired securities of Nano-X during the period from March 31, 2025, to April 17, 2026. Pomerantz LLP is advocating for those affected investors to recover losses attributed to misleading statements made by the company and its executives regarding Nano-X's business operations and prospects. The allegations emphasize violations of key sections of the Securities Exchange Act of 1934.

If you are an investor impacted by these events, Pomerantz is encouraging you to act promptly; you have until August 11, 2026, to request the Court to appoint you as the Lead Plaintiff. Interested parties can access a copy of the complaint through the firm’s website, and inquiries can be made directly to attorney Danielle Peyton via email or phone.

About Nano-X Imaging

Founded with the intent to revolutionize diagnostic imaging technology, Nano-X Imaging is focused on the development of a commercial-grade tomographic imaging device powered by a digital X-ray source. The firm also provides teleradiology services and innovates AI applications tailored for medical imaging. Their production includes intricate components like micro-electro-mechanical systems used in X-ray devices.

Throughout the Class Period, Nano-X's executives have made assurances about the company's operational efficiency and scalable manufacturing capabilities, which they touted as essential for meeting expected product demand post regulatory approvals. However, the case details highlight that fundamental operational misalignments were present.

Allegations and Misleading Statements

The lawsuit alleges that the Nano-X leadership inflated claims regarding the operational improvements and demand for its products. Specifically, it raises concerns that:

• - The management overstated the efficiency advancements realized in their operations.
• - In reality, the production capacity of Nano-X was not synchronized with the market demand.
• - This led to surging operational expenses and cash burn, exposing the company to significant financial strain.
• - There were clear indicators that adjustments would be necessary to the manufacturing structure, incurring substantial restructuring fees.

These claims aim to establish that the information disseminated to the investors was materially deceptive and failed to accurately reflect the company's condition.

The pivotal moment for the case came on April 20, 2026, when Nano-X publicly disclosed its Q4 financial results, revealing a substantial net loss of $33.4 million, largely due to a financial charge linked to the impairment of long-term assets following a restructuring of its operations in Korea. During an earnings call, both the CFO Ran Daniel and CEO Erez Meltzer confirmed the need for a fundamental realignment of their production strategy to mitigate unnecessary operational expenditure and adapt to the actual market demands.

Impact and Stock Price Fallout

These significant revelations led to an immediate impact on Nano-X’s stock price, which fell by approximately 24.39%, closing at $2.155 per share following the disclosures. Such volatility underlines the heightened scrutiny facing the company and the potential implications for its stakeholders.

Pomerantz LLP has built a legacy as a frontrunner in corporate law and class action suits, having recouped billions of dollars for their clients over the years. Founded by Abraham L. Pomerantz, a pioneer in securities litigation, the firm stands committed to battling for the rights of those who fell victim to corporate wrongdoing and securities fraud. For more information about this case or to engage with legal assistance, please visit their official website at www.pomlaw.com.